Sep 30, 2021 / 04:40PM GMT
Emma Nealon - Cantor Fitzgerald - Analyst
Good afternoon, everyone, and thank you for joining us on day four of the virtual Cantor healthcare conference. My name is Emma Nealon, and I'm one of the small mid-cap biotech analysts here at Cantor. It's my pleasure to introduce our next presenting company, Daré Bioscience. And joining us today from Daré is CEO, Sabrina Johnson. Sabrina, I'll turn it over to you to take us through the story.
Sabrina Johnson - DaréBioscience - Inc. - President & CEO
Thank you so much and thank you to everyone who's listening in. I always appreciate the opportunity to share our story at Daré. So before I get started, I will say that today's presentation does contain forward-looking statements. So please do take a look at our SEC filings for a full disclosure of the risks and uncertainties.
So for those of you who are not as familiar with the Company, I did want to start briefly with an overview of who we are and what we do. And those of you who know us know that women's health is our sole focus
Dare Bioscience Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 30, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers